[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
Spaëth
D
D
Département d'oncologie médicale, centre Alexis-Vautrin, avenue de Bourgogne, 54511 Vandoeuvre-lès-Nancy Cedex.
Geoffrois
L
L
Conroy
T
T
D000740:Anemia / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor